- •MicroRNAs were deregulated in the hippocampal tissue of SAMP8 mice.
- •miR-181 levels decreased with aging in the hippocampus tissue.
- •miR-181c directly targeted the 3′-UTR of crmp2 mRNA.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is usually accompanied by abnormal gene expression. The 20 to 25 nucleotide (nt) tiny regulators, known as micro ribonucleic acids (miRNAs), have been found to play important roles in the etiology and pathogenesis of various biological processes. The purpose of the current study was to identify the aberrant expression of microRNAs in the hippocampus of an AD mouse model and to investigate its potential role during the progression of AD. The results from microarray analysis showed that several miRNAs were deregulated in the hippocampus tissue of SAMP8 mice compared to SAMR1 mice. Among the deregulated miRNAs, a significant decrease in miR-181c was validated by quantitative real-time PCR. Bioinformatic analysis revealed that miR-181c might be involved in the regulation of axon guidance, MAPK signaling, dorso-ventral axis formation and long-term depression. Moreover, the results of a luciferase activity assay, western blot analysis and immunofluorescent staining showed that over-expression of miR-181c targets the 3′-untranslated region (3′-UTR) of collapsin response mediator protein 2 (crmp2) through its binding sites and down-regulates crmp2 protein abundance at the post-transcriptional level. Taken together, these findings suggested that crmp2 is a target of miR-181c and that the abnormally low expression of miR-181c in the hippocampus of SAMP8 mice could lead to an increase of the crmp2 protein level in AD mice, which might potentially play a role in the pathogenesis of Alzheimer's disease.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Neurological Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Toxic proteins in neurodegenerative disease.Science. 2002; 296 (PMID: 12065827): 1991-1995
- Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.J. Neurosci. Res. 2002; 70 (PMID: 12391607): 462-473
- Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.Hum. Mol. Genet. 2011; 20 (PMID: 21459773): 2495-2509
- MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice.Neurobiol. Aging. 2012; 33 (PMID: 20619502): 522-534
- MicroRNAs: genomics, biogenesis, mechanism, and function.Cell. 2004; 116 (PMID: 14744438): 281-297
- Quantification of microRNA-210 in the cerebrospinal fluid and serum: implications for Alzheimer's disease.Exp. Ther. Med. 2015; 9 (PMID: 25667669): 1013-1017
- MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease.EMBO J. 2014; 33 (PMID: 25001178): 1667-1680
- MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.Neurobiol. Aging. 2014; 35 (PMID: 23962497): 152-158
- Opposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218/PTPA pathway.Aging Cell. 2015; 14 (PMID: 26111662): 867-877
- The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease.Biochim. Biophys. Acta. 2012; 1822 (PMID: 22142563): 650-656
- The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease.Exp. Gerontol. 2005; 40 (PMID: 16026957): 774-783
- Senescence-accelerated mouse (SAM): a novel murine model of accelerated senescence.J. Am. Geriatr. Soc. 1991; 39 (PMID: 1885867): 911-919
- Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice.J. Neurol. Sci. 2014; 338 (PMID: 24423585): 57-64
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.Nat. Protoc. 2009; 4 (PMID: 19131956): 44-57
- Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model.Front. Aging Neurosci. 2013; 5 (PMID: 24194717): 65
- MicroRNA profiling in human colon cancer cells during 5-fluorouracil-induced autophagy.PLoS One. 2014; 9 (PMID: 25526515): e114779
- MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.BMC Infect. Dis. 2014; 14 (PMID: 25231540): 506
- Development and immunity-related microRNAs of the lepidopteran model host Galleria mellonella.BMC Genomics. 2014; 15 (PMID: 25149864): 705
- Oxidative stress mediated-alterations of the microRNA expression profile in mouse hippocampal neurons.Int. J. Mol. Sci. 2012; 13 (PMID: 23443129): 16945-16960
- Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex.Neurosci. Lett. 2009; 459 (PMID: 19406203): 100-104
- MicroRNA turnover: when, how, and why.Trends Biochem. Sci. 2012; 37 (PMID: 22921610): 436-446
- Age-dependent regulation of tumor-related microRNAs in the brain of the annual fish Nothobranchius furzeri.Mech. Ageing Dev. 2012; 133 (PMID: 22487494): 226-233
- Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta.J. Mol. Neurosci. 2012; 46 (PMID: 21720722): 324-335
- Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways.J. Alzheimers Dis. 2008; 14 (PMID: 18525125): 27-41
- Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.Neuroreport. 2015; 26 (PMID: 25494473): 66-73
- MicroRNA-181c negatively regulates the inflammatory response in oxygen-glucose-deprived microglia by targeting Toll-like receptor 4.J. Neurochem. 2015; 132 (PMID: 25545945): 713-723
- miR-181c promotes proliferation via suppressing PTEN expression in inflammatory breast cancer.Int. J. Oncol. 2015; 46 (PMID: 25695913): 2011-2020
- MiR-181c modulates the proliferation, migration, and invasion of neuroblastoma cells by targeting Smad7.Acta Biochim. Biophys. Sin. Shanghai. 2014; 46 (PMID: 24345480): 48-55
- Identification of a microRNA regulator for axon guidance in the olfactory bulb of adult mice.Gene. 2014; 547 (PMID: 24345480): 319-328
- The combination of transcriptomics and informatics identifies pathways targeted by miR-204 during neurogenesis and axon guidance.Nucleic Acids Res. 2014; 42 (PMID: 24895435): 7793-7806
- CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases.J. Alzheimers Dis. 2011; 27 (PMID: 21860090): 615-625
- Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression.J. Neurochem. 2007; 103 (PMID: 17683481): 1132-1144
- The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling.Cell Death Differ. 2015; 22 (PMID: 25501601): 583-596
- Protein phosphatase 2A facilitates axonogenesis by dephosphorylating CRMP2.J. Neurosci. 2010; 30 (PMID: 20220019): 3839-3848
- Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.Genes Cells. 2005; 10 (PMID: 15676027): 165-179
- CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer's disease patients.J. Alzheimers Dis. 2013; 33 (PMID: 22954668): 349-355
- Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders.Mol. Neurobiol. 2003; 28 (PMID: 14514985): 51-64
- Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.Brain Res. 2004; 1018 (PMID: 15262209): 86-96
- Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus.J. Neurosci. Res. 2015; 93 (PMID: 26250894): 1684-1692
Published online: May 19, 2016
Accepted: May 18, 2016
Received in revised form: May 5, 2016
Received: February 5, 2016
© 2016 Elsevier B.V. All rights reserved.